Inventor · disambiguated record
Nathan Stehle
Also filed as: STEHLE NATHAN · STEHLE NATHAN W
11 granted patents·5 pending applications·111 citations·filing 2000–2018
90Inventor score
Top patents by PatentIndex Score
16 records- 0194US9480754B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2016·Granted Nov 1, 2016·11 cites·3 claims
- 0294US9345718B1Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2015·Granted May 24, 2016·12 cites·2 claims
- 0389US9925269B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2015·Granted Mar 27, 2018·4 cites·9 claims
- 0488US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 0586US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 0679US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 0773US6750233B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2001·Granted Jun 15, 2004·6 cites·103 claims
- 0869US6890937B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2003·Granted May 10, 2005·4 cites·39 claims
- 0967US11439709B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2018·Granted Sep 13, 2022·0 cites·11 claims
- 1061US8183401B2Exemestane and its intermediates and methods of making the sameKUNNEN KEVIN·Filed 2005·Granted May 22, 2012·1 cites·16 claims
- 1153US2004127519A1Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1251US2006084688A1Aromatic sulfone hydroxamic acid metalloprotease inhibitorBARTA THOMAS E·Filed 2005·Application pending·0 cites
- 1351US2004235818A1Aromatic sulfone hydroxamic acid metalloprotease inhibitorFiled 2003·Application pending·0 cites
- 1450US8541609B2Exemestane and its intermediates and methods of making the sameKUNNEN KEVIN·Filed 2012·Granted Sep 24, 2013·0 cites·3 claims
- 1550US2004209914A1Aromatic sulfone hydroxamic acids and their use as protease inhibitorsFiled 2003·Application pending·0 cites
- 1644US2004142978A1Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2PHARMACIA CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathan Stehle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →